Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Blood Management in Cardiac Surgery by Erythropoietin, Ferric Carboxymaltose and Metabolic Adjustment (ScvO2): A Randomized Controlled Study

NCT04141631 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04141631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Blood Management in Cardiac Surgery by Erythropoietin, Ferric Carboxymaltose and Metabolic Adjustment (ScvO2): A Randomized Controlled Study
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2020
Completion date
June 15, 2022
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, perioperative anemia, transfusion